StockTipsArenaBeta

BUY Anthem Biosciences Limited — Jefferies India

BUYAnthem Biosciences Limited

byJefferies IndiaHorizon: NA (inferred 1 year)21 Aug 2026via Zee Business (Live)

Entry₹893Inferred
Target₹1,050
Total upside +17.58%
Stop lossNot given
CMP₹934.052d ago
Active+4.60%+12.41%upside left 12 mo left
Follow Jefferies India for new calls(100% target hit, 27 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 1 other Long-term call on ANTHEM

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 5:15 am IST
10 supporting8 neutral1 opposing
Supports the BUY call (10)

Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target

NewsEt-Markets·21 Aug · 2w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·22 Jul · 2mo ago

Neutral / worth noting (8)

Anthem Biosciences, Shivalik Bimetal Garner Brokerage Attention

NewsGoogle News·27 Aug · 1w ago

(opens in new tab)

Anthem Biosciences, Shivalik Bimetal: బ్రోకరేజ్ సంస్థల రేడార్‌లోకి కొత్త స్టాక్స్!

NewsGoogle News·27 Aug · 1w ago

(opens in new tab)

JSW Steel, Anthem Biosciences ਅਤੇ eClerx: ਟੈਕਨੀਕਲ ਐਨਾਲਿਸਟ ਨੇ ਦਿੱਤੇ ਵੱਡੇ ਸੰਕੇਤ, ਜਾਣੋ ਕਿਹੜੇ ਲੈਵਲ 'ਤੇ ਰੱਖੀਏ ਨਜ਼ਰ

NewsGoogle News·27 Aug · 1w ago

(opens in new tab)

Anthem Biosciences Share: दमदार FY26 नतीजे, पर Q1 FY27 में आई नरमी, निवेशक इन बातों पर रख रहे नज़र

NewsGoogle News·10 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.